Clinical Trial Update: Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated switching to a basal insulin regimen with insulin glargine in adults with Type 2 diabetes mellitus previously not controlled …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED